| Product Code: ETC12838728 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Influenza Vaccines Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Influenza Vaccines Market - Industry Life Cycle |
3.4 Egypt Influenza Vaccines Market - Porter's Five Forces |
3.5 Egypt Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Egypt Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.7 Egypt Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Egypt Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Egypt Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination in Egypt |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Rise in healthcare expenditure and infrastructure development in Egypt |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas of Egypt |
4.3.2 Vaccine hesitancy and misinformation among certain population groups |
5 Egypt Influenza Vaccines Market Trends |
6 Egypt Influenza Vaccines Market, By Types |
6.1 Egypt Influenza Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Egypt Influenza Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Egypt Influenza Vaccines Market Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031F |
6.1.4 Egypt Influenza Vaccines Market Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031F |
6.1.5 Egypt Influenza Vaccines Market Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031F |
6.2 Egypt Influenza Vaccines Market, By Strain Type |
6.2.1 Overview and Analysis |
6.2.2 Egypt Influenza Vaccines Market Revenues & Volume, By Trivalent Vaccines, 2021 - 2031F |
6.2.3 Egypt Influenza Vaccines Market Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031F |
6.3 Egypt Influenza Vaccines Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Egypt Influenza Vaccines Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Egypt Influenza Vaccines Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Egypt Influenza Vaccines Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Egypt Influenza Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Egypt Influenza Vaccines Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.3 Egypt Influenza Vaccines Market Revenues & Volume, By Nasal Spray, 2021 - 2031F |
7 Egypt Influenza Vaccines Market Import-Export Trade Statistics |
7.1 Egypt Influenza Vaccines Market Export to Major Countries |
7.2 Egypt Influenza Vaccines Market Imports from Major Countries |
8 Egypt Influenza Vaccines Market Key Performance Indicators |
8.1 Number of vaccination campaigns organized by the government |
8.2 Percentage increase in vaccination coverage rates |
8.3 Number of healthcare facilities offering influenza vaccination services |
9 Egypt Influenza Vaccines Market - Opportunity Assessment |
9.1 Egypt Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Egypt Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
9.3 Egypt Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Egypt Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Egypt Influenza Vaccines Market - Competitive Landscape |
10.1 Egypt Influenza Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Egypt Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here